NDC 50242-041
Cathflo Activase
Alteplase
Cathflo Activase is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Alteplase.
| Product ID | 50242-041_02610895-08f1-4af5-a022-265a2c36c795 |
| NDC | 50242-041 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cathflo Activase |
| Generic Name | Alteplase |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2001-09-04 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103172 |
| Labeler Name | Genentech, Inc. |
| Substance Name | ALTEPLASE |
| Active Ingredient Strength | 2 mg/2mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |